| Amgen (AMGN) |
United States |
$116.342B |
13.25 |
| Gilead Sciences (GILD) |
United States |
$84.042B |
10.32 |
| CSL (CSLLY) |
Australia |
$72.428B |
0.00 |
| Celgene (CELG) |
United States |
$69.903B |
10.81 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$44.326B |
47.90 |
| Illumina (ILMN) |
United States |
$43.735B |
51.38 |
| Biogen (BIIB) |
United States |
$42.849B |
7.61 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$31.212B |
14.17 |
| Actelion (ALIOF) |
Switzerland |
$29.891B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$24.275B |
12.80 |
| SINO PHARMACEUT (SBMFF) |
China |
$17.750B |
0.00 |
| Incyte (INCY) |
United States |
$16.360B |
48.15 |
| Exact Sciences (EXAS) |
United States |
$14.074B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$13.065B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$12.366B |
69.36 |
| Seattle Genetics (SGEN) |
United States |
$11.463B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$10.123B |
54.27 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$9.249B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$8.775B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$7.685B |
25.24 |
| Bio-Techne Corp (TECH) |
United States |
$7.575B |
52.33 |
| Guardant Health (GH) |
United States |
$7.163B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$6.540B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$6.319B |
0.00 |
| Amarin (AMRN) |
Ireland |
$5.983B |
0.00 |
| Exelixis (EXEL) |
United States |
$5.834B |
15.16 |
| Bluebird Bio (BLUE) |
United States |
$5.699B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$5.655B |
0.00 |
| Moderna (MRNA) |
United States |
$5.415B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$4.928B |
12.53 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.772B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$4.406B |
0.00 |
| Repligen (RGEN) |
United States |
$4.071B |
79.01 |
| Spark Therapeutics (ONCE) |
United States |
$4.066B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.934B |
24.56 |
| Blueprint Medicines (BPMC) |
United States |
$3.880B |
0.00 |
| Medicines (MDCO) |
United States |
$3.852B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.692B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.554B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$3.329B |
0.00 |
| Immunomedics (IMMU) |
United States |
$3.018B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$2.794B |
41.97 |
| Genomic Health (GHDX) |
United States |
$2.710B |
50.82 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.626B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.620B |
5.63 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$2.578B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.564B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.541B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.493B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$2.434B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.413B |
0.00 |
| NeoGenomics (NEO) |
United States |
$2.342B |
125.28 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.226B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.040B |
21.41 |
| Cambrex (CBM) |
United States |
$2.010B |
25.41 |
| Zai Lab (ZLAB) |
China |
$1.964B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.957B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.863B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.855B |
23.45 |
| UniQure (QURE) |
Netherlands |
$1.838B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.826B |
0.00 |
| Insmed (INSM) |
United States |
$1.696B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.456B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.391B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$1.369B |
0.00 |
| Alector (ALEC) |
United States |
$1.346B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.345B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.292B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.285B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$1.178B |
0.00 |
| Innoviva (INVA) |
United States |
$1.176B |
3.39 |
| AnaptysBio (ANAB) |
United States |
$1.159B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$1.141B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.105B |
0.00 |
| Athenex (ATNX) |
United States |
$1.085B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.022B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.016B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$0.941B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.921B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.882B |
459.75 |
| Arvinas (ARVN) |
United States |
$0.879B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.877B |
14.64 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.843B |
0.00 |
| Codexis (CDXS) |
United States |
$0.829B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.826B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$0.815B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.771B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.756B |
26.76 |
| Cytokineticsorporated (CYTK) |
United States |
$0.739B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.734B |
8.51 |
| Vericel (VCEL) |
United States |
$0.729B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.727B |
26.25 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.723B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.721B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.706B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.636B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.578B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.577B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.572B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.561B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.557B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.535B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.526B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.506B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.504B |
0.00 |
| Heska (HSKA) |
United States |
$0.500B |
64.82 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.498B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.492B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.480B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.474B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.460B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.459B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.451B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.440B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.424B |
0.00 |
| Agenus (AGEN) |
United States |
$0.422B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.418B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.415B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.395B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.388B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.385B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.384B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.382B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.365B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.363B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.355B |
26.25 |
| Prothena (PRTA) |
Ireland |
$0.348B |
0.00 |
| Theratechnologies (THERF) |
Canada |
$0.325B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.319B |
477.09 |
| Albireo Pharma (ALBO) |
United States |
$0.318B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.312B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.310B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.309B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.306B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.304B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.304B |
0.00 |
| Geron (GERN) |
United States |
$0.298B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.285B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.280B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.276B |
0.00 |
| MannKind (MNKD) |
United States |
$0.271B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.271B |
6.97 |
| Seres Therapeutics (MCRB) |
United States |
$0.270B |
0.00 |
| Prometic Life Sciences (PFSCF) |
Canada |
$0.266B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.266B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.258B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.258B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.257B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.256B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.251B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.246B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.244B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.240B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.232B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.231B |
0.00 |
| Athersys (ATHX) |
United States |
$0.226B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.216B |
6.67 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.215B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.213B |
8.12 |
| Compugen (CGEN) |
Israel |
$0.210B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.202B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.199B |
0.00 |
| EXICURE INC (XCUR) |
United States |
$0.195B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.195B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.191B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.191B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.188B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.185B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.184B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.182B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.170B |
0.00 |
| XOMA (XOMA) |
United States |
$0.168B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.167B |
0.00 |
| Newron Pharmaceuticals SpA (NWPHF) |
|
$0.165B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.163B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.163B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.162B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.161B |
0.00 |
| Cerecor (CERC) |
United States |
$0.161B |
0.00 |
| BioTime (LCTX) |
United States |
$0.156B |
10.40 |
| Abeona Therapeutics (ABEO) |
United States |
$0.155B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.152B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.148B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.147B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.146B |
6.00 |
| Dyadic (DYAI) |
United States |
$0.142B |
0.00 |
| Adocia (ADOCY) |
France |
$0.140B |
0.00 |
| Novavax (NVAX) |
United States |
$0.137B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.134B |
0.00 |
| NantKwest (NK) |
United States |
$0.131B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.129B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.128B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.126B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.124B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.109B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.107B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.106B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.106B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.099B |
0.00 |
| Verastem (VSTM) |
United States |
$0.097B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.096B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.093B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.089B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.087B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.087B |
0.00 |
| Trevena (TRVN) |
United States |
$0.086B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.083B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.082B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
Canada |
$0.081B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.080B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.080B |
0.00 |
| OvaScience (MLND) |
United States |
$0.079B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.077B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.077B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.074B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.073B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.072B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.072B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.072B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.070B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.068B |
37.30 |
| Curis (CRIS) |
United States |
$0.066B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.066B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.065B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.065B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.063B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.062B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.059B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.058B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.053B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.049B |
0.00 |
| Ophthotech (ISEE) |
United States |
$0.049B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.047B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.047B |
0.00 |
| AmpliPhi Biosciences (ARMP) |
United States |
$0.046B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.045B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.044B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.042B |
0.00 |
| INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.039B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.039B |
0.00 |
| Stellar Biotechnologies (EDSA) |
Canada |
$0.038B |
0.00 |
| Celsion (CLSN) |
United States |
$0.037B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.036B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.035B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.034B |
0.00 |
| BIOCARDIA INC (BCDA) |
United States |
$0.033B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.033B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.031B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.030B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.030B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.029B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.028B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.028B |
0.00 |
| Apricus Biosciences (SEEL) |
United States |
$0.027B |
0.00 |
| Caladrius Biosciences (CLBS) |
United States |
$0.026B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.023B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.022B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.018B |
0.00 |
| Fibrocell Science Inc (FCSC) |
United States |
$0.018B |
6.10 |
| Pulmatrix (PULM) |
United States |
$0.017B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.016B |
0.00 |
| IBio (IBIO) |
United States |
$0.016B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.015B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.015B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.015B |
0.00 |
| Vical (BBI) |
United States |
$0.014B |
0.00 |
| Novelion Therapeutics (NVLN) |
Canada |
$0.014B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.014B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.013B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.012B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.011B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.010B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.010B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.008B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.008B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.006B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.005B |
0.00 |
| Hemispherx BioPharma (AIM) |
United States |
$0.005B |
0.00 |
| BioPharmX (BPMX) |
United States |
$0.004B |
0.00 |
| Neuralstem (CUR) |
United States |
$0.004B |
0.00 |
